Follow the 인바디 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 인바디 has recorded 19 public disclosures. The latest transaction was reported on 26 June 2026 (Other). Among the most active insiders: 차인준. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
19 of 19 declarations
InBody is a company specializing in the development of body composition technology and health solutions. It is listed on the XKRX market.